0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acne Vulgaris Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-10O6249
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Acne Vulgaris Market Insights and Forecast to 2028
BUY CHAPTERS

Global Acne Vulgaris Market Research Report 2023

Code: QYRE-Auto-10O6249
Report
April 2023
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Acne Vulgaris Market

Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin.
The global Acne Vulgaris market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Acne Vulgaris is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, the glands become blocked.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Acne Vulgaris, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Vulgaris.
The Acne Vulgaris market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acne Vulgaris market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acne Vulgaris companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Global Acne Vulgaris Market Report

Report MetricDetails
Report NameGlobal Acne Vulgaris Market
Base Year2022
Forecasted years2023-2029
By Company
  • Allergan
  • Bayer
  • Cipher
  • Hygeia Laboratories
  • Johnson & Johnson
  • Bausch Health
  • Novan
  • Vyome Bioscience
Segment by Type
  • Tetracycline
  • Minocycline
  • Doxycycline
  • Clindamycin
  • Others
Segment by Application
  • Child
  • Adult
  • Elderly
By Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Acne Vulgaris companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acne Vulgaris Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tetracycline
1.2.3 Minocycline
1.2.4 Doxycycline
1.2.5 Clindamycin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acne Vulgaris Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acne Vulgaris Market Perspective (2018-2029)
2.2 Acne Vulgaris Growth Trends by Region
2.2.1 Global Acne Vulgaris Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acne Vulgaris Historic Market Size by Region (2018-2023)
2.2.3 Acne Vulgaris Forecasted Market Size by Region (2024-2029)
2.3 Acne Vulgaris Market Dynamics
2.3.1 Acne Vulgaris Industry Trends
2.3.2 Acne Vulgaris Market Drivers
2.3.3 Acne Vulgaris Market Challenges
2.3.4 Acne Vulgaris Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Players by Revenue
3.1.1 Global Top Acne Vulgaris Players by Revenue (2018-2023)
3.1.2 Global Acne Vulgaris Revenue Market Share by Players (2018-2023)
3.2 Global Acne Vulgaris Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acne Vulgaris Revenue
3.4 Global Acne Vulgaris Market Concentration Ratio
3.4.1 Global Acne Vulgaris Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Revenue in 2022
3.5 Acne Vulgaris Key Players Head office and Area Served
3.6 Key Players Acne Vulgaris Product Solution and Service
3.7 Date of Enter into Acne Vulgaris Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Breakdown Data by Type
4.1 Global Acne Vulgaris Historic Market Size by Type (2018-2023)
4.2 Global Acne Vulgaris Forecasted Market Size by Type (2024-2029)
5 Acne Vulgaris Breakdown Data by Application
5.1 Global Acne Vulgaris Historic Market Size by Application (2018-2023)
5.2 Global Acne Vulgaris Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acne Vulgaris Market Size (2018-2029)
6.2 North America Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acne Vulgaris Market Size by Country (2018-2023)
6.4 North America Acne Vulgaris Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acne Vulgaris Market Size (2018-2029)
7.2 Europe Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acne Vulgaris Market Size by Country (2018-2023)
7.4 Europe Acne Vulgaris Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Market Size (2018-2029)
8.2 Asia-Pacific Acne Vulgaris Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acne Vulgaris Market Size by Region (2018-2023)
8.4 Asia-Pacific Acne Vulgaris Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acne Vulgaris Market Size (2018-2029)
9.2 Latin America Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acne Vulgaris Market Size by Country (2018-2023)
9.4 Latin America Acne Vulgaris Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Market Size (2018-2029)
10.2 Middle East & Africa Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acne Vulgaris Market Size by Country (2018-2023)
10.4 Middle East & Africa Acne Vulgaris Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Acne Vulgaris Introduction
11.1.4 Allergan Revenue in Acne Vulgaris Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Acne Vulgaris Introduction
11.2.4 Bayer Revenue in Acne Vulgaris Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Cipher
11.3.1 Cipher Company Detail
11.3.2 Cipher Business Overview
11.3.3 Cipher Acne Vulgaris Introduction
11.3.4 Cipher Revenue in Acne Vulgaris Business (2018-2023)
11.3.5 Cipher Recent Development
11.4 Hygeia Laboratories
11.4.1 Hygeia Laboratories Company Detail
11.4.2 Hygeia Laboratories Business Overview
11.4.3 Hygeia Laboratories Acne Vulgaris Introduction
11.4.4 Hygeia Laboratories Revenue in Acne Vulgaris Business (2018-2023)
11.4.5 Hygeia Laboratories Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Acne Vulgaris Introduction
11.5.4 Johnson & Johnson Revenue in Acne Vulgaris Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Detail
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Acne Vulgaris Introduction
11.6.4 Bausch Health Revenue in Acne Vulgaris Business (2018-2023)
11.6.5 Bausch Health Recent Development
11.7 Novan
11.7.1 Novan Company Detail
11.7.2 Novan Business Overview
11.7.3 Novan Acne Vulgaris Introduction
11.7.4 Novan Revenue in Acne Vulgaris Business (2018-2023)
11.7.5 Novan Recent Development
11.8 Vyome Bioscience
11.8.1 Vyome Bioscience Company Detail
11.8.2 Vyome Bioscience Business Overview
11.8.3 Vyome Bioscience Acne Vulgaris Introduction
11.8.4 Vyome Bioscience Revenue in Acne Vulgaris Business (2018-2023)
11.8.5 Vyome Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Acne Vulgaris Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Tetracycline
    Table 3. Key Players of Minocycline
    Table 4. Key Players of Doxycycline
    Table 5. Key Players of Clindamycin
    Table 6. Key Players of Others
    Table 7. Global Acne Vulgaris Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Acne Vulgaris Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Acne Vulgaris Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Acne Vulgaris Market Share by Region (2018-2023)
    Table 11. Global Acne Vulgaris Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Acne Vulgaris Market Share by Region (2024-2029)
    Table 13. Acne Vulgaris Market Trends
    Table 14. Acne Vulgaris Market Drivers
    Table 15. Acne Vulgaris Market Challenges
    Table 16. Acne Vulgaris Market Restraints
    Table 17. Global Acne Vulgaris Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Acne Vulgaris Market Share by Players (2018-2023)
    Table 19. Global Top Acne Vulgaris Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris as of 2022)
    Table 20. Ranking of Global Top Acne Vulgaris Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Acne Vulgaris Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Acne Vulgaris Product Solution and Service
    Table 24. Date of Enter into Acne Vulgaris Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Acne Vulgaris Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Acne Vulgaris Revenue Market Share by Type (2018-2023)
    Table 28. Global Acne Vulgaris Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Acne Vulgaris Revenue Market Share by Type (2024-2029)
    Table 30. Global Acne Vulgaris Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Acne Vulgaris Revenue Market Share by Application (2018-2023)
    Table 32. Global Acne Vulgaris Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Acne Vulgaris Revenue Market Share by Application (2024-2029)
    Table 34. North America Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Acne Vulgaris Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Acne Vulgaris Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Acne Vulgaris Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Acne Vulgaris Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Acne Vulgaris Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Acne Vulgaris Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Acne Vulgaris Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Allergan Company Detail
    Table 50. Allergan Business Overview
    Table 51. Allergan Acne Vulgaris Product
    Table 52. Allergan Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 53. Allergan Recent Development
    Table 54. Bayer Company Detail
    Table 55. Bayer Business Overview
    Table 56. Bayer Acne Vulgaris Product
    Table 57. Bayer Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 58. Bayer Recent Development
    Table 59. Cipher Company Detail
    Table 60. Cipher Business Overview
    Table 61. Cipher Acne Vulgaris Product
    Table 62. Cipher Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 63. Cipher Recent Development
    Table 64. Hygeia Laboratories Company Detail
    Table 65. Hygeia Laboratories Business Overview
    Table 66. Hygeia Laboratories Acne Vulgaris Product
    Table 67. Hygeia Laboratories Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 68. Hygeia Laboratories Recent Development
    Table 69. Johnson & Johnson Company Detail
    Table 70. Johnson & Johnson Business Overview
    Table 71. Johnson & Johnson Acne Vulgaris Product
    Table 72. Johnson & Johnson Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 73. Johnson & Johnson Recent Development
    Table 74. Bausch Health Company Detail
    Table 75. Bausch Health Business Overview
    Table 76. Bausch Health Acne Vulgaris Product
    Table 77. Bausch Health Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 78. Bausch Health Recent Development
    Table 79. Novan Company Detail
    Table 80. Novan Business Overview
    Table 81. Novan Acne Vulgaris Product
    Table 82. Novan Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 83. Novan Recent Development
    Table 84. Vyome Bioscience Company Detail
    Table 85. Vyome Bioscience Business Overview
    Table 86. Vyome Bioscience Acne Vulgaris Product
    Table 87. Vyome Bioscience Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
    Table 88. Vyome Bioscience Recent Development
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acne Vulgaris Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Acne Vulgaris Market Share by Type: 2022 VS 2029
    Figure 3. Tetracycline Features
    Figure 4. Minocycline Features
    Figure 5. Doxycycline Features
    Figure 6. Clindamycin Features
    Figure 7. Others Features
    Figure 8. Global Acne Vulgaris Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Acne Vulgaris Market Share by Application: 2022 VS 2029
    Figure 10. Child Case Studies
    Figure 11. Adult Case Studies
    Figure 12. Elderly Case Studies
    Figure 13. Acne Vulgaris Report Years Considered
    Figure 14. Global Acne Vulgaris Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Acne Vulgaris Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Acne Vulgaris Market Share by Region: 2022 VS 2029
    Figure 17. Global Acne Vulgaris Market Share by Players in 2022
    Figure 18. Global Top Acne Vulgaris Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Acne Vulgaris Revenue in 2022
    Figure 20. North America Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Acne Vulgaris Market Share by Country (2018-2029)
    Figure 22. United States Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Acne Vulgaris Market Share by Country (2018-2029)
    Figure 26. Germany Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Acne Vulgaris Market Share by Region (2018-2029)
    Figure 34. China Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Acne Vulgaris Market Share by Country (2018-2029)
    Figure 42. Mexico Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Acne Vulgaris Market Share by Country (2018-2029)
    Figure 46. Turkey Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Acne Vulgaris Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Allergan Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 49. Bayer Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 50. Cipher Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 51. Hygeia Laboratories Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 52. Johnson & Johnson Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 53. Bausch Health Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 54. Novan Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 55. Vyome Bioscience Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS